Beigene Ltd ADR (BGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BGNE | AMGN | GILD | VRTX | BIIB |
| Company | Beigene Ltd ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 143.45 | 270.63 | 66.58 | 404.50 | 198.97 |
| High | 146.22 | 274.45 | 67.12 | 406.83 | 205.75 |
| Low | 141.78 | 269.65 | 66.37 | 399.37 | 198.97 |
| Last | 142.47 | 274.02 | 67.02 | 400.07 | 202.76 |
| Change | +3.48 | +0.48 | -0.01 | -4.84 | +9.58 |
| % Change | +2.50% | +0.18% | -0.01% | -1.20% | +4.96% |
| Volume | 92,187 | 531,061 | 2,218,689 | 280,840 | 1,497,917 |
| 20-Day Average Volume | 154,989 | 2,073,098 | 6,168,365 | 942,512 | 1,169,775 |
| Previous Close | 138.99 | 273.54 | 67.03 | 404.91 | 193.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 144.76 | 271.60 | 69.06 | 403.32 | 202.13 |
| 20-Day Raw Stochastic | 49.79% | 48.00% | 11.36% | 34.28% | 42.27% |
| 20-Day Relative Strength | 45.12% | 49.22% | 32.17% | 45.30% | 42.00% |
| Weighted Alpha | -42.60 | +11.74 | -21.23 | +16.36 | -34.98 |
| Today's Opinion | 100% Sell | 40% Sell | 100% Sell | 8% Buy | 100% Sell |
| Previous Opinion | 100% Sell | 40% Sell | 100% Sell | 24% Buy | 100% Sell |
| Last Month's Opinion | 80% Sell | 24% Buy | 88% Sell | 40% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.51% since 04/17/24 | +3.78% since 04/17/24 | -0.19% since 04/17/24 | +2.12% since 04/17/24 | +4.77% since 04/17/24 |
| Low | 126.97 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 146.04 on 04/24/24 | 274.48 on 04/23/24 | 67.68 on 04/23/24 | 406.86 on 04/23/24 | 205.75 on 04/24/24 |
| 1-Month | |||||
| %Chg | -5.88% since 03/22/24 | -0.76% since 03/22/24 | -7.99% since 03/22/24 | -3.42% since 03/22/24 | -7.69% since 03/22/24 |
| Low | 126.97 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 159.34 on 04/01/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 218.26 on 03/25/24 |
| 3-Month | |||||
| %Chg | -10.96% since 01/24/24 | -10.29% since 01/24/24 | -16.00% since 01/24/24 | -6.11% since 01/24/24 | -18.54% since 01/24/24 |
| Low | 126.97 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 184.80 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 | 251.99 on 01/31/24 |
| 6-Month | |||||
| %Chg | -17.27% since 10/24/23 | -0.74% since 10/24/23 | -14.52% since 10/24/23 | +8.68% since 10/24/23 | -20.14% since 10/24/23 |
| Low | 126.97 on 04/19/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 205.40 on 11/14/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 13,293,002 | 146,720,288 | 83,457,512 | 104,652,640 | 28,080,836 |
| Shares Outstanding, K | 95,640 | 536,376 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 2,458,780,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -881,710,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 634,410,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | -367,550,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | 0.61 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -3.53 on 02/26/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.58 | 9.96 | 29.76 | 13.18 |